Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 1307-1311, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, M.
Right arrow Articles by Jackowski, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, M.
Right arrow Articles by Jackowski, G.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1999;45:1307-1311.)
© 1999 American Association for Clinical Chemistry, Inc.

Technical Briefs

Rapid and Sensitive Immunoassay for the Measurement of Serum S100B Using Isoform-specific Monoclonal Antibody

Miyoko Takahashia, Andrea Chamczuk, Yuwen Hong and George Jackowski

Skye PharmaTech, Inc., 6354 Viscount Rd., Mississauga, ON L4V 1H3, Canada
a author for correspondence: fax 905-677-1674, e-mail empty@ICA.net

S100 is an acidic calcium-binding protein with a molecular weight of 21 000, originally discovered by Moore (1) in the bovine brain. Today, >14 different S100 members are known (2), of which S100A1 and S100B are the most studied (3)(4)(5)(6). Because a high concentration of S100B is present in the brain, S100 has been studied for use as a biochemical marker for central nervous system pathology. Numerous studies in the literature have suggested the clinical usefulness of measuring this protein in cerebrospinal fluid (7)(8)(9)(10)(11), and in recent years, serum S100B has been reported as a useful marker for early detection of metastases of melanoma and cerebral complications from head injury, cardiac surgery, and acute stroke (12)(13)(14)(15)(16)(17)(18)(19)(20)(21).

With the advent of therapeutic treatments for stroke that either dissolve the clot or protect the brain, early diagnosis of stroke and the identification of appropriate patients for intervention are increasingly important. Existing assays lack sensitivity and ease of use and usually require >=3 h to perform. We have, therefore, developed an ELISA that is rapid, highly sensitive, and S100B specific. This ELISA was used to retrospectively assess S100B concentrations in the serum of stroke patients.

Human S100B cDNA (Genome System), amplified by PCR, was cloned into vector pET28a (Novagen) and expressed in Escherichia coli BL-21 (DE3)pLysS (Novagen). Recombinant human S100B (rS100B) was isolated from host cells that were induced with 1 mmol/L isopropylthio-ß-galactoside for 2 h at 37 °C and were lysed with a native buffer system. S100B was purified with an Ni-NTA affinity column.

The ELISA buffers were as follows: . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
 StrokeHome page
W. Whiteley, M.-C. Tseng, and P. Sandercock
Blood Biomarkers in the Diagnosis of Ischemic Stroke: A Systematic Review
Stroke, October 1, 2008; 39(10): 2902 - 2909.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. C. Jauch, C. Lindsell, J. Broderick, S. C. Fagan, B. C. Tilley, S. R. Levine, and for the NINDS rt-PA Stroke Study Group
Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study
Stroke, October 1, 2006; 37(10): 2508 - 2513.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
C. G. Zimmermann-Ivol, P. R. Burkhard, J. Le Floch-Rohr, L. Allard, D. F. Hochstrasser, and J.-C. Sanchez
Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke: A Pilot Study
Mol. Cell. Proteomics, January 1, 2004; 3(1): 66 - 72.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. O. Mbele, J. C. Deloulme, B. J. Gentil, C. Delphin, M. Ferro, J. Garin, M. Takahashi, and J. Baudier
The Zinc- and Calcium-binding S100B Interacts and Co-localizes with IQGAP1 during Dynamic Rearrangement of Cell Membranes
J. Biol. Chem., December 13, 2002; 277(51): 49998 - 50007.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
M. D. Hill, G. Jackowski, N. Bayer, M. Lawrence, and R. Jaeschke
Biochemical markers in acute ischemic stroke
Can. Med. Assoc. J., April 1, 2000; 162(8): 1139 - 1140.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.